Menu
ncarol.com
  • Home
  • Business
  • Sports
  • Books
  • Real Estate
  • Arts
  • Property
  • Automotive
  • Marketing
ncarol.com

Labcorp Plans Laboratory Expansion in Japan Through BML Collaboration
ncarol.com/10179892

Trending...
  • SPECTRAFORCE® Listed in Everest Group's
  • insightsoftware Introduces New Features in Logi Composer 7 Launch, Addressing BI Market Needs
  • America's Boating Channel Launches CAPACITY COMPLIANCE
Download
  • Full Size
  • Small
  • Preview
  • Thumbnail

Photo courtesy of Labcorp
  • Photo courtesy of Labcorp
    • Full Size
    • Small
    • Preview
    • Thumbnail

    • Full Size
    • Small
    • Preview
    • Thumbnail


BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services.

Extending their strategic relationship that dates back more than a decade, Labcorp Drug Development and BML will begin work on a new laboratory facility in the city of Kawagoe, Saitama, expanding capacity and services for pharmaceutical and biotechnology clients. This will bolster Labcorp Drug Development's central laboratory services offerings in Japan and sets the stage for a continued acceleration of companion diagnostic capabilities.

More on ncarol.com
  • The Forest at Duke and Caspar.AI partner on Technology in New Health Center "Small Houses"
  • Leading Plaintiffs Firm Grant & Eisenhofer Represents U.S. Military Service Members Harmed by Contaminated Water at Camp Lejeune
  • Jay Menger Awarded Prestigious "Premier Luxury Marketing Consultant" Certification
  • Palos Verdes Real Estate Agent Promotes Luxury Homes To MORE Buyers For MORE Money
  • Regent Surgical Health and Ascension Texas Joint Venture on The Orthopedic Surgery Center of Central Texas

"Labcorp Drug Development remains committed to growing its Japanese operations and services through continued expansion and partnerships," said Honggang Bi, senior vice president and head of Asia-Pacific for Labcorp Drug Development. "Broadening our work with BML and increasing our laboratory footprint means we will be able to offer shorter turnaround times, superior in-country sample management and full lab testing services for global clinical trials in Japan. This will benefit patients, clients and health care providers by providing them with the information needed to make key decisions."

The new facility will be located near BML's General Laboratory in Kawagoe where the current CB Trial Laboratory is located, providing over 4,000 square meters of dedicated space for global clinical trials managed by Labcorp Drug Development. The new space will be greater than five times the size of the current facility, with additional capabilities such as genomics, microbiology and companion diagnostics in addition to expanded offerings in current lab capabilities including flow cytometry, immunology, and anatomical pathology and histology. Completion of the expanded laboratory is expected by early 2025.

Through the planned laboratory expansion, Labcorp will advance biomarker and esoteric testing services, expand its companion diagnostics portfolio and deepen the integration with its clinical development services. In addition, the company will be able to intensify its focus on cell and gene therapy research and development, part of a broader commitment to precision medicine and fortifying the company's position as an oncology leader.

"In collaborating with Labcorp, we are able to offer our pharmaceutical and biotechnology clients access to both comprehensive clinical laboratory testing and drug development opportunities," said Dr. Kensuke Kondo, president of BML. "The laboratory expansion provides additional capabilities and capacity and opens the door to enriched services, more resources and better outcomes for our clients and patients."

Labcorp and BML have successfully provided central laboratory services for global clinical trials in Japan since 2010 through kit production, sample logistics and laboratory operations at CB Trial Laboratory. Their partnership agreement was renewed in 2020.

To learn more about Labcorp Drug Development's Japanese operations, please click here.

More on ncarol.com
  • Arizona Pest Control To Support Local High School Sports And Education Programs
  • MetLife Doubles Down on Technology Hiring in North Carolina
  • Grammy Award Winning Singer, Songwriter and Producer David Longoria Joins the List of Artists at VANC Fest 2022
  • Positive Powerful Women Gather to Promote Unity in the Grand Canyon State
  • Serenity Movers Delivers First-Class Moving Services in NYC

About Labcorp
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.

This press release contains forward-looking statements, including but not limited to statements with respect to future prospects for services to be offered in Japan through the collaboration between Labcorp and BML, and its anticipated benefits for clients and patients.

Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the company's control. These factors, in some cases, have affected and in the future (together with other factors) could affect the company's ability to implement the company's business strategy and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of the forward-looking statements.

The company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the company's most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the company's other filings with the SEC. The information in this press release should be read in conjunction with a review of the company's filings with the SEC including the information in the company's most recent Annual Report on Form 10-K, and subsequent Forms 10-Q, under the heading MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.


Contacts

Media: Christopher Allman-Bradshaw — 336-436-8263
Media@Labcorp.com

Investors: Chas Cook — 336-436-5076
Investor@Labcorp.com

0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>

Contacts

Media: Christopher Allman-Bradshaw — 336-436-8263
Media@Labcorp.com

Investors: Chas Cook — 336-436-5076
Investor@Labcorp.com
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Kinugawa Onsen Celebrates its 330th Anniversary AND Kawagoe City Celebrates its 100th Anniversary - Both with Fireworks!
  • Aiwyn To Sponsor PrimeGlobal Mega Week
  • Carter Hensley: Nascar Dreamin' & Off to the Races!
  • Curtiss-Wright to Participate in Jefferies 2022 Industrials Conference
  • America's Boating Channel Launches CAPACITY COMPLIANCE
  • JELD-WEN Announces Leadership Changes
  • VA Center of North County Hosts It's First Annual VANC Fest; an Art, Music and Culinary Experience
  • American Momentum Bank enters Raleigh market with key SBA lending hire
  • 10 Years in the Making: #LatinaGeeks Celebrates 10th Anniversary with Inaugural Inspirada Awards & Fundraising Gala
  • Winston-Salem Weaver fire air quality worse than reported by agencies
  • North Carolina: Governor Cooper Addresses NC Offshore Wind Potential at NC TOWERS Taskforce Meeting, Tours Dominion Energy Wind Turbines
  • Cornerstone Building Brands Names Award-Winning Country Music Artist Tyler Hubbard Home for Good Project Celebrity Ambassador
  • SPECTRAFORCE® Listed in Everest Group's
  • Guerrilla RF Common Stock Begins Trading
  • 3i Solutions Announces New Leadership Brings a Customer-Focused Approach
  • insightsoftware Introduces New Features in Logi Composer 7 Launch, Addressing BI Market Needs
  • Kinston Railroad Commences Rail Operations
  • Cornerstone Building Brands Signs CEO Action for Diversity & Inclusion Commitment
  • Help Wanted: Oakland-Based Children Rising Seeks Volunteers to Help Students Overcome COVID-Related Learning Loss
  • E3 Forensic Platform Innovates again with Remote Cloud Collection
_catLbl0 _catLbl1

Popular on ncarol.com

  • North Carolina: Governor Offers Reward for Information on Northampton County Murder
  • VolunteerNC Announces $11.5 Million in AmeriCorps Grants to 21 North Carolina Organizations
  • Brandon Andrews Discusses Shark Tank Casting on Bloomberg Black Business Beat
  • ServisFirst Bank Announces Expansion to Western North Carolina
  • Action Termite and Pest Control Opens New Office in Blackwood, NJ
  • New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions
  • UNice Hair Celebrates Brand Day With More Exclusive Hair Deals
  • Axiros Selected by Connect Fibre UK to Manage Their FTTH Router Estate
  • The ITeam Ranked on Prestigious Channel Futures 2022 MSP 501
  • LOWE'S LAUNCHES FIRST-EVER "INTO THE BLUE: LOWE'S PRODUCT PITCH EVENT," INVITING ENTREPRENEURS AND BUSINESSES TO APPLY FOR A CHANCE TO BECOME LOWE'S SUPPLIERS

Similar on ncarol.com

  • The Forest at Duke and Caspar.AI partner on Technology in New Health Center "Small Houses"
  • Leading Plaintiffs Firm Grant & Eisenhofer Represents U.S. Military Service Members Harmed by Contaminated Water at Camp Lejeune
  • Regent Surgical Health and Ascension Texas Joint Venture on The Orthopedic Surgery Center of Central Texas
  • Arizona Pest Control To Support Local High School Sports And Education Programs
  • MetLife Doubles Down on Technology Hiring in North Carolina
  • Positive Powerful Women Gather to Promote Unity in the Grand Canyon State
  • Unprecedented Stress Levels Reveal Productivity Loss in the Billions; ASCEND Method Enters the Market
  • Tech Luminary Adrian Cockcroft Joins OrionX as Partner
  • Parsonex Capital Partners Launches Credit Enhancement Facility with Fast Growing Class 8 Truck Lease Origination Company
  • Brighthouse Financial Expands Flagship Shield Level Annuity Suite With New Product That Provides Guaranteed Lifetime Income
Copyright © 2022 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute